R. Kent McGaughy Jr., Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 17,000 shares at $28.47 ($484K) on 2017-12-29, disclosed to the SEC on 2017-12-29.
Open-market purchase of $484k RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| TIL | BUY | 2021-03-25 | $9.0M | — | Filing → |
| APEN | BUY | 2020-07-21 | $2.2M | — | Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |